Fitnib 250mg Tablet
Marketer
Zen Pharma Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Fitnib 250mg Tablet
Afinitinib 250mg tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer treatment. Dosage should strictly follow your physician's instructions, continuing therapy as directed. Treatment length depends on individual response and needs. Regular liver function tests may be recommended. Common side effects include nausea, dry skin, appetite loss, and diarrhea. Increased fluid intake may mitigate side effects. Report any persistent or worsening side effects, especially mouth sores, visual disturbances, or respiratory problems. Women should employ effective contraception throughout treatment and for one month post-treatment to prevent pregnancy. Always inform your doctor of all other medications you are currently using.
Uses of Fitnib 250mg Tablet
Lung cancer (excluding small cell)
Major Benefits of Fitnib 250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Fitnib 250mg Tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Fitnib 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Fitnib 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the 250mg Fitnib tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Fitnib 250mg Tablet works:
Oncaspare 250mg tablets are an anticancer drug. Their mechanism involves inhibiting the activity of a mutated protein responsible for triggering cancer cell proliferation. This action serves to suppress or reduce the rate of cancer cell dissemination.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Fitnib 250mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Fitnib 250mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's unsafe. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Fitnib 250mg tablets while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Fitnib 250mg Tablet might impair your driving ability due to potential adverse reactions.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Fitnib 250mg tablets. Dosage modification may be necessary. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Fitnib 250mg Tablet in individuals with liver conditions is likely safe. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Fitnib 250mg Tablet :
Omit any missed Fitnib 250mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Fitnib 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently